{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/kazia-therapeutics-expands-oncology-platform-with-first-in-class-setdb1-inhibitor-drug-development-platform-302740954.html", "message": "News view counter 660848 successfully enlarged"}